期刊文献+

冠通方治疗冠心病慢性心力衰竭疗效观察 被引量:6

Effective Observation of Adding Guantong Decoction for Treatment of the Coronary Heart Disease with Chronic Heart Failure
下载PDF
导出
摘要 目的观察冠通方治疗冠心病慢性心力衰竭的临床疗效。方法选择80例冠心病慢性心力衰竭患者,随机分为治疗组和对照组,每组40例。两组均采用西医治疗方案,并在此基础上治疗组加用冠通方,疗程20周。观察中医证候、心功能分级、生活质量、左室射血分数以及血浆脑钠素(BNP)浓度。结果中医证候疗效,治疗组和对照组总有效率分别为87.5%和67.5%,两组比较有统计学意义(P<0.05)。心功能疗效,治疗组和对照组总有效率分别为77.5%和57.5%,两组比较有统计学意义(P<0.05)。治疗组改善左室射血分数优于对照组(P<0.05)。治疗组改善患者生活质量优于对照组(P<0.05)。治疗组血浆脑钠素浓度较对照组降低明显(P<0.05)。安全性观察,治疗组和对照组无明显不良反应。结论冠通方能改善冠心病慢性心力衰竭患者心功能,具有明显疗效及良好的安全性。 Objective To evaluate the clinic effect of Guantong decoction on the patients(pts) with chronic heart failure(CHF) and coronary heart disease(CHD).Methods Eighty pts with CHF were assigned randomly to two groups:Control group treated by western medicine,and treatment group treated by western medicine and Guantong decoction.Effect of traditional Chinese medicine(TCM) symptoms,cardiac function(CF),quality of life(QOL),left ventricular ejection fraction(LVEF),and brain natriuretic peptide(BNP) were studied.Results The total effective rate of TCM symptoms in the treatment group was 87.5% and that in control group was 67.5%(P0.05).Improvement of CF in treatment group was 77.5% and that in control group was 57.5%(P0.05).QOL in treatment group showed a better efficiency than that in control group(P0.05).The level of BNP in treatment group was lower than that in control group(P0.05).No obvious adverse effect was found in both groups.Conclusion Guantong decoction could improve cardiac function in the pts with CHF and it was effective and safety.
出处 《中西医结合心脑血管病杂志》 2012年第3期261-263,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 广西科技厅自然资金项目(No.桂科自0640141) 广西卫生厅资助项目(No.Z2009210)
关键词 冠通方 冠心病 慢性心力衰竭 中西医结合治疗 Guantong decoction coronary heart disease chronic heart failure integrative medical therapy
  • 相关文献

参考文献5

  • 1陆再英,钟南山,主编.内科学[M].第7版.北京:人民卫生出版社,2008:778-779.
  • 2国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:85-89.
  • 3Rector TS,Kubo SH,Cohn JN.Validity of the Minnesdta livingheart failure question naire as a measure of therapeutic response toenlapril or placbo[J].Am J Cardiol,1993,71:1106-1112.
  • 4Adams KF.New epidemiologic perspectives concerning mild-to-moderate heart failure[J].Am J Med,2001,110(17):6-13.
  • 5王强,莫雪梅,何劲松,易自刚,苏毅强.冠通方对冠状动脉裸金属支架植入术后再狭窄和IL-8水平的影响[J].南京中医药大学学报,2011,27(1):27-29. 被引量:2

二级参考文献7

  • 1胜国印,贾国良,陈士良.冠心病患者血浆IL-8的变化及临床意义[J].临床心血管病杂志,1995,11(6):353-354. 被引量:10
  • 2Ockene IS, Matthews CE, Rifai N, et al. Variability and cassification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults [J]. Clinical Chemistry,2001,47(3) :444 - 450.
  • 3GaspardoneA,Crea F,Versaci F,et al. Predictive value of ereactive protein after successful coronary--artery stenting in patients with stable angina[J].Am J Cardio, 1998,82(2)-515.
  • 4Stringer KA. TIMI grade flow, mortality, and the GVSTO- III trial[J].Pharmacotherapy, 1998,18 (4):699 - 705.
  • 5余佳霖,叶天星,陆德源.现代医学免疫学[M].上海:上海医科大学出版社,1998:136.
  • 6齐晓勇.冠心病介入治疗前后白细胞介素-8变化的意义.河北医科大学学报,2002,(2):34-35.
  • 7陈灏珠.实用内科学[M]12版.北京:人民卫生出版社,2005.1746-1750.

共引文献726

同被引文献78

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部